[go: up one dir, main page]

ES2072280T3 - Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf). - Google Patents

Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf).

Info

Publication number
ES2072280T3
ES2072280T3 ES89118628T ES89118628T ES2072280T3 ES 2072280 T3 ES2072280 T3 ES 2072280T3 ES 89118628 T ES89118628 T ES 89118628T ES 89118628 T ES89118628 T ES 89118628T ES 2072280 T3 ES2072280 T3 ES 2072280T3
Authority
ES
Spain
Prior art keywords
tnf
induction
necrosis factor
tumor necrosis
catabolic enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89118628T
Other languages
English (en)
Inventor
Karl Ransberger
Gerhard Dr Stauder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucos Emulsion GmbH
Original Assignee
Mucos Emulsion GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mucos Emulsion GmbH filed Critical Mucos Emulsion GmbH
Application granted granted Critical
Publication of ES2072280T3 publication Critical patent/ES2072280T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL INVENTO SE REFIERE A LA APLICACION DE ENZIMAS SELECCIONADAS DEL GRUPO (PANCRATINA, BROMELAINA, PAPAINA, LIPASA, AMILASA, TRIPSINA Y/O QUINOTRIPSINA), PARA LA INDUCCION DE FACTOR DE NECROSIS DE TUMORES (TNF) Y DESCRIBE LA ACCION DEL TNF COMO TERAPEUTICO PARA EL CANCER Y ATACA SELECTIVAMENTE LAS CALULAS DE CANCER SIN DAÑAR LAS CELULAS ESTABLES.
ES89118628T 1989-10-06 1989-10-06 Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf). Expired - Lifetime ES2072280T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89118628A EP0421023B1 (de) 1989-10-06 1989-10-06 Katabolische Enzyme zur Induktion des Tumornekrose-Faktors (TNF)

Publications (1)

Publication Number Publication Date
ES2072280T3 true ES2072280T3 (es) 1995-07-16

Family

ID=8201995

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89118628T Expired - Lifetime ES2072280T3 (es) 1989-10-06 1989-10-06 Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf).

Country Status (6)

Country Link
US (1) US5223406A (es)
EP (1) EP0421023B1 (es)
AT (1) ATE119780T1 (es)
DE (1) DE58909121D1 (es)
ES (1) ES2072280T3 (es)
GR (1) GR3015924T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
CZ283972B6 (cs) * 1995-05-17 1998-07-15 František Mudr. Trnka Farmaceutický prostředek s modulačním účinkem na zhoubné nádory a jeho použití
WO1998038320A1 (en) 1997-02-25 1998-09-03 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
DE19726255C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
DE19726253C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Verwendung von mindestens einem proteolytischen Enzym und Rutosid zur Behandlung von Glomerulonephritis
DE19726248C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Behandlung von septischem Schock
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
US20080139790A1 (en) * 2006-12-08 2008-06-12 Jennings Philip A Chimeric antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
DE3785036D1 (de) * 1987-09-30 1993-04-29 Mucos Emulsionsgesellschaft Mb Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).

Also Published As

Publication number Publication date
US5223406A (en) 1993-06-29
DE58909121D1 (de) 1995-04-20
GR3015924T3 (en) 1995-07-31
ATE119780T1 (de) 1995-04-15
EP0421023B1 (de) 1995-03-15
EP0421023A1 (de) 1991-04-10

Similar Documents

Publication Publication Date Title
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
EA200400632A1 (ru) Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
YU8997A (sh) Prečišćen protein koji ima serinsku proteaznu inhibitorsku aktivnost i farmaceutski preparat koji ga sadrži
NZ506783A (en) Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
ES2072280T3 (es) Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf).
FI961976A0 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
DE3271549D1 (en) Agent for the prevention and treatment of liver and kidney diseases
BR9608326A (pt) Fragmentos de angiostatina e angiostatina agregada e processos de uso.
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
AU6458396A (en) Phosphorous-containing cysteine and serine protease inhibitors
ATE277943T1 (de) Trypsininhibitoren
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE131066T1 (de) Mittel zur hemmung von hiv-proteasen.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
EP0960117A4 (en) ON FIBROBLASTS GROWTH FACTOR HOMOLOGICAL FACTORS (FHFs) AND METHOD OF APPLICATION
EP0743070A3 (de) Verwendung von Protease-Proenzymen und Amylasen als Wirkstoffe in pharmazeutischen Mitteln zur Krebstherapie sowie ihre Herstellung
EP0674001A2 (en) Novel protease for treating devitalized tissue
EA200001164A1 (ru) КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
DE60044038D1 (de) Xylosyltransferase und isoformen
AU2821000A (en) Matrix protein compositions for induction of apoptosis
CO4920227A1 (es) Histidina-n-bencil glicinamida sustituida con cicloalquilos .
AP2003002901A0 (en) Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
Yusupbekova MODERN ASPECTS OF THE USE ENZYMES IN DENTISTRY (LITERATURE REVIEW)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421023

Country of ref document: ES